Satoshi Okubo

1.2k total citations
58 papers, 866 citations indexed

About

Satoshi Okubo is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Satoshi Okubo has authored 58 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 20 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Satoshi Okubo's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Liver Disease Diagnosis and Treatment (8 papers). Satoshi Okubo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Liver Disease Diagnosis and Treatment (8 papers). Satoshi Okubo collaborates with scholars based in Japan and United States. Satoshi Okubo's co-authors include Bernard S. Strauss, Marvin Stodolsky, Toshio Yanagida, W. R. Romig, Junichi Shindoh, Masaji Hashimoto, Hiroaki Nakayama, Y. Takagi, Yuta Kobayashi and Masahiro Sekiguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Satoshi Okubo

53 papers receiving 752 citations

Peers

Countries citing papers authored by Satoshi Okubo

Since Specialization

Citations

This map shows the geographic impact of Satoshi Okubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Okubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Okubo more than expected).

Fields of papers citing papers by Satoshi Okubo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Okubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Okubo. The network helps show where Satoshi Okubo may publish in the future.

Co-authorship network of co-authors of Satoshi Okubo

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Okubo. A scholar is included among the top collaborators of Satoshi Okubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Okubo. Satoshi Okubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proposal of a Modified Adhesion Score as a Predictor of Technical Difficulty and Surgical Risks of Repeat Hepatectomy: The TORAD Score, Version 2.0 2025 ·Journal of Hepato-Biliary-Pancreatic Sciences ·(unknown), Yuta Kobayashi, Satoshi Okubo, (unknown), Hisashi Murakami, (unknown), Masaru Matsumura, Masaji Hashimoto	0
2	Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy 2024 ·Hepatology Research ·Yusuke Kawamura, Norio Akuta, (unknown), Masaru Matsumura, Satoshi Okubo, Licht Tominaga, Shigeki Yamamoto, (unknown), Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, K Ikeda, (unknown), Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada	2
3	Clinical Utility of the Novel Oncological Criteria of Resectability for Advanced Hepatocellular Carcinoma 2024 ·Liver Cancer ·Junichi Shindoh, Yusuke Kawamura, Keiichi Akahoshi, Masaru Matsumura, Satoshi Okubo, Norio Akuta, Minoru Tanabe, Norihiro Kokudo, Yoshiyuki Suzuki, Masaji Hashimoto	4
4	Efficacy and safety of postoperative preemptive use of tolvaptan for patients with cirrhosis undergoing hepatectomy for hepatocellular carcinoma 2023 ·Langenbeck s Archives of Surgery ·Yuta Kobayashi, Junichi Shindoh, (unknown), Miho Akabane, Masahiro Kobayashi, Satoshi Okubo, Masaru Matsumura, Masaji Hashimoto	0
5	Disease-Free Interval and Tumor Stage Complementarily Predict the Biological Behavior of Recurrent Hepatocellular Carcinoma 2023 ·Annals of Surgical Oncology ·Junichi Shindoh, Masaru Matsumura, Masahiro Kobayashi, Miho Akabane, Satoshi Okubo, Masaji Hashimoto	7
6	Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma 2023 ·Cancers ·Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Licht Tominaga, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada	9
7	Risk Stratification of Patients with Marginal Hepatic Functional Reserve Using the Remnant Hepatocyte Uptake Index in Gadoxetic Acid‐Enhanced Magnetic Resonance Imaging for Safe Liver Surgery 2023 ·World Journal of Surgery ·Miho Akabane, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Masaru Matsumura, Masaji Hashimoto	1
8	Gallbladder cancer concomitant with autosomal dominant polycystic kidney disease: A case report 2022 ·SHILAP Revista de lepidopterología ·Hisashi Murakami, Satoshi Okubo, Masahiro Kobayashi, Miho Akabane, (unknown), Junichi Shindoh, Masaji Hashimoto	1
9	Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma 2022 ·Clinical Journal of Gastroenterology ·Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Licht Tominaga, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada	5
10	Prognostic Advantages of Individual Additional Interventions After Lenvatinib Therapy in Patients with Advanced Hepatocellular Carcinoma 2022 ·Journal of Gastrointestinal Surgery ·Junichi Shindoh, Yusuke Kawamura, Masahiro Kobayashi, Norio Akuta, Satoshi Okubo, Masaru Matsumura, Yoshiyuki Suzuki, Masaji Hashimoto	9
11	Indocyanine green fluorescence angiography-guided simultaneous laparoscopic distal gastrectomy and spleen-preserving distal pancreatectomy for conserving the gastrosplenic ligament 2022 ·International Journal of Surgery Case Reports ·(unknown), Satoshi Okubo, Shusuke Haruta, Junichi Shindoh, Masaji Hashimoto, Masaki Ueno	5
12	Pretreatment Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment 2021 ·Oncology ·Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, (unknown), Soichi Iritani, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Hiromitsu Kumada	3
13	Adipose Tissue Distribution Predicts Prognosis of Cirrhotic Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 2021 ·Annals of Surgical Oncology ·Satoshi Okubo, Junichi Shindoh, Yuta Kobayashi, (unknown), Miho Akabane, (unknown), Masaji Hashimoto	9
14	Significance of preoperative nutritional status as a predictor for short-term and long-term outcomes of patients undergoing surgery for stage IV colorectal cancer 2021 ·Langenbeck s Archives of Surgery ·Miho Akabane, Junichi Shindoh, Yuta Kobayashi, (unknown), (unknown), Satoshi Okubo, Masaji Hashimoto, Shuichiro Matoba, Hiroya Kuroyanagi	5
15	A novel scoring system for evaluating the difficulty of lysis of adhesion and surgical risk at repeat hepatectomy 2020 ·Journal of Hepato-Biliary-Pancreatic Sciences ·Yuta Kobayashi, Junichi Shindoh, (unknown), Satoshi Okubo, Masaji Hashimoto	15
16	Hyaluronic acid/ carboxymethyl cellulose-based adhesion barrier reduces surgical difficulty and complication in repeat hepatectomy 2020 ·HPB ·Yuta Kobayashi, Junichi Shindoh, Satoshi Okubo, Keigo Tani, (unknown), (unknown), (unknown), (unknown), Miho Akabane, Masaji Hashimoto	6
17	Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma 2020 ·Annals of Surgical Oncology ·Junichi Shindoh, Yuta Kobayashi, (unknown), (unknown), Satoshi Okubo, Masaji Hashimoto	14
18	Safety of bioabsorbable membrane (Seprafilim®) in hepatectomy in the era of aggressive liver surgery 2020 ·HPB ·Satoshi Okubo, Junichi Shindoh, Yuta Kobayashi, Masaji Hashimoto	8
19	Potential and Clinical Significance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment 2020 ·Oncology ·(unknown), Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, (unknown), (unknown), Soichi Iritani, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Hiromitsu Kumada	7
20	Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity test 2012 ·Oncology Letters ·(unknown), Kazuhiko Nishimura, Tomoo Watanabe, Masayuki Kitajima, (unknown), (unknown), Marie Washio, (unknown), Tsuyoshi Sato, (unknown), Takanori Ochi, Satoshi Okubo, Shunji Futagawa, (unknown), Isao Nagaoka	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact